Free Trial
NASDAQ:CRON

Cronos Group (CRON) Stock Price, News & Analysis

Cronos Group logo
$1.88 +0.04 (+1.89%)
As of 03:33 PM Eastern

About Cronos Group Stock (NASDAQ:CRON)

Key Stats

Today's Range
$1.80
$1.92
50-Day Range
$1.62
$2.05
52-Week Range
$1.60
$3.14
Volume
2.65 million shs
Average Volume
1.42 million shs
Market Capitalization
$726.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.50
Consensus Rating
N/A

Company Overview

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Cronos Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
28th Percentile Overall Score

CRON MarketRank™: 

Cronos Group scored higher than 28% of companies evaluated by MarketBeat, and ranked 722nd out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Cronos Group are expected to grow in the coming year, from ($0.03) to $0.03 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cronos Group is -14.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cronos Group is -14.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Cronos Group has a PEG Ratio of 1.74. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Cronos Group has a P/B Ratio of 0.66. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Cronos Group's valuation and earnings.
  • Percentage of Shares Shorted

    2.04% of the float of Cronos Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Cronos Group has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cronos Group has recently decreased by 4.27%, indicating that investor sentiment is improving.
  • Dividend Yield

    Cronos Group does not currently pay a dividend.

  • Dividend Growth

    Cronos Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.04% of the float of Cronos Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Cronos Group has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cronos Group has recently decreased by 4.27%, indicating that investor sentiment is improving.
  • News Sentiment

    Cronos Group has a news sentiment score of 0.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.85 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Cronos Group this week, compared to 2 articles on an average week.
  • Search Interest

    2 people have searched for CRON on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cronos Group insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.90% of the stock of Cronos Group is held by insiders.

  • Percentage Held by Institutions

    Only 8.71% of the stock of Cronos Group is held by institutions.

  • Read more about Cronos Group's insider trading history.
Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

CRON Stock News Headlines

New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.
See More Headlines

CRON Stock Analysis - Frequently Asked Questions

Cronos Group's stock was trading at $2.02 at the beginning of 2025. Since then, CRON shares have decreased by 6.7% and is now trading at $1.8850.
View the best growth stocks for 2025 here
.

Cronos Group Inc. (NASDAQ:CRON) issued its quarterly earnings data on Thursday, August, 8th. The company reported ($0.02) earnings per share (EPS) for the quarter. The firm had revenue of $27.76 million for the quarter, compared to analysts' expectations of $25.85 million. Cronos Group had a negative trailing twelve-month return on equity of 2.56% and a negative net margin of 42.65%.
Read the conference call transcript
.

Top institutional shareholders of Cronos Group include SeaCrest Wealth Management LLC (0.08%) and IMC Chicago LLC.
View institutional ownership trends
.

Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cronos Group investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
8/08/2024
Today
4/30/2025
Next Earnings (Estimated)
5/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CRON
Fax
N/A
Employees
450
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$3.50
High Stock Price Target
$3.50
Low Stock Price Target
$3.50
Potential Upside/Downside
+93.9%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
1.74
Net Income
$-73,960,000.00
Pretax Margin
-49.33%

Debt

Sales & Book Value

Annual Sales
$117.62 million
Price / Cash Flow
N/A
Book Value
$2.87 per share
Price / Book
0.63

Miscellaneous

Free Float
356,136,000
Market Cap
$695.66 million
Optionable
Optionable
Beta
1.02
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:CRON) was last updated on 4/30/2025 by MarketBeat.com Staff
From Our Partners